JStone
Rookie
- Jun 29, 2011
- 13,374
- 254
- 0
- Banned
- #1
Warren Buffett: "If you go to the Middle East looking for oil, you don't need to stop in Israel. But, if you're looking for brains, for energy, for integrity, for imagination, it's the only stop you need to make"
http://asweetlife.org/a-sweet-life-...ideo-the-artificial-pancreas-in-action/21243/
Israeli-Developed 'Artificial Pancreas’ Tested
http://asweetlife.org/a-sweet-life-...ideo-the-artificial-pancreas-in-action/21243/
Israeli-Developed 'Artificial Pancreas’ Tested
Apparently for the first time in the world, a recent research study on children with type 1 (insulin-dependent, juvenile- onset) diabetes aimed at creating an effective artificial pancreas to produce insulin was held not in a hospital but in a hotel.
The clinical trial was conducted by specialists at the Schneider Children’s Medical Center (SCMC) at the Kibbutz Ma’aleh Hahamisha Hotel outside Jerusalem. The prospective, crossover study, in which the whole group receive the treatment but at different times, was part of the three-day DREAM (Diabetes wireless Artificial pancreas consortium) Camp for Children with Diabetes.
It consisted of 18 kids aged 12 to 15 years; nine of them were were connected to the artificial pancreas system on the first night of the camp, while eight were connected on the second night. The benefit of being in a hotel rather than a hospital ward was that the more pleasant, non-threatening environment made the results more accurate.
The MD-Logic Artificial Pancreas, developed at the SCMS’s Institute for Endocrinology and Diabetes, consists of an off-the-shelf subcutaneous glucose sensor that monitors glucose levels, and an insulin pump. The sensor and pump are connected to a computer that programs the information and stipulates the amount of insulin that should be released to the body in order to maintain blood glucose balance.
This innovation “closes the loop” between the sensor and the pump and relieves the patients with diabetes from the daily burden of dealing with their diabetes and has the potential to significantly improve the quality of life of patients with diabetes.
The experimental artificial pancreas is aimed at providing a real solution for patients with type 1 diabetes, which usually begins in early childhood. The research is being carried out at the Shaffer Institute for Endocrinology and Diabetes at the Petah Tikva hospital’s National Center of Childhood Diabetes. The project is headed by institute director Prof. Moshe Phillip and Dr. Revital.
Following the successful trial, Phillip said: “I am proud to head and be a part of the pioneering team working for a number of years to find a technological solution that will significantly improve the lives of millions of diabetics around the world. The MD-Logic Artificial Pancreas and the DREAM Projects will enable patients to be relieved of the continuous need to check glucose levels and inject insulin, while ensuring long-term balance which significantly reduces the chance of complications from diabetes. The entire staff in the Institute is excited to be part of this important historic project.”
“This is a significant landmark in research,” he added. “This is, to the best of our knowledge, the first time in the world that such a trial project has been taken outside the hospital, illustrating a normal life for youngsters with diabetes, while using an automatic insulin delivery system during the night.” The overall success of the research represents genuine good news to millions of patients with diabetes in Israel and the world, he said.
Con't: Israeli-developed 'artificial pancrea... JPost - Health & Science
Last edited: